CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

argenx signs agreement to buy Forte Biosciences for $2.2bn

Positive
AI Analysis

Summary

argenx has entered into a definitive agreement to acquire Forte Biosciences for approximately $2.2 billion in total equity value.

Importance:7/10
Sentiment:
0.60
M&Aacquisitiondefinitive agreement
Related Companies

Read the original article

Published by Pharmaceutical Technology on July 28, 2026 8:35 AM

Read Original